| Haab, Brian B. |
Van Andel Research Institute
United States |
Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers |
5U01CA226158-05 |
Matthew Young, Ph.D. |
| Kibel, Adam S |
Brigham And Women'S Hospital
United States |
Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer |
5U01CA268810-02 |
Richard Mazurchuk, Ph.D. |
| Peppone, Luke Joseph |
University Of Rochester
United States |
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients |
5R01CA258349-03 |
Marge Good, R.N., M.P.H., O.C.N. |
| Hruska, Carrie B |
Mayo Clinic Rochester
United States |
Density MATTERS Clinical Trial |
5R01CA239200-04 |
Claire Zhu, Ph.D. |
| Bast, Robert C |
University Of Tx Md Anderson Can Ctr
United States |
MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm |
2U01CA200462-06A1 |
Christos Patriotis, Ph.D., M.Sc. |
| Watt, Gordon Patrick |
Sloan-Kettering Inst Can Research
United States |
Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk |
1R37CA284134-01A1 |
Claire Zhu, Ph.D. |
| Radisky, Derek C |
Mayo Clinic Jacksonville
United States |
Involution-based biomarkers of breast cancer risk |
3R01CA237602-04S1 |
Christos Patriotis, Ph.D., M.Sc. |
| Hu, Shuiying |
Ohio State University
United States |
Targeting neuronal transport to ameliorate vincristine neurotoxicity |
1R01CA272254-01A1 |
Rachel Altshuler, Ph.D. |
| Chirenje, Zvavahera Mike |
University Of California, San Francisco
United States |
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE) |
1UG1CA284918-01 |
Silvina Frech, Ph.D., M.S. |
| Taouli, Bachir |
Icahn School Of Medicine At Mount Sinai
United States |
Abbreviated MRI for HCC screening in cirrhotic patients |
5R01CA249765-04 |
Guillermo Marquez, Ph.D. |